Advanced search
Publication Cover
Cancer Biology & Therapy Volume 20, 2019 - Issue 5
Submit an article Journal homepage
1,380
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways

Dong CuiDepartment of Thyroid Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of ChinaCorrespondence[email protected]
,
Yongfu ZhaoDepartment of Thyroid Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China
&
Jingchao XuDepartment of Thyroid Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China
Pages 608-616 | Received 04 Apr 2018, Accepted 17 Oct 2018, Published online: 07 Nov 2018

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Shuo Li, Miao Yu, Xiuying Wang & Bingyuan Fei. (2023) MiR-597-5p inhibits carcinogenesis and macrophage recruitment in colitis-related colorectal cancer via reducing the expression of CXCL5. Cancer Biology & Therapy 24:1.
Read now
Wang Chang, Qing Chang, Haodong Lu, Shiguang Liu, Yanbing Li & Chunyou Chen. (2022) MicroRNA-873-5p suppresses cell malignant behaviors of thyroid cancer via targeting CXCL5 and regulating P53 pathway. Human Vaccines & Immunotherapeutics 18:5.
Read now
Liangliang Huang, Yuhuai Cai, Yi Luo, Daigang Xiong, Zeyu Hou, Junyuan Lv, Feng Zeng, Yan Yang & Xiaoming Cheng. (2019) JAZF1 Suppresses Papillary Thyroid Carcinoma Cell Proliferation and Facilitates Apoptosis via Regulating TAK1/NF-κB Pathways. OncoTargets and Therapy 12, pages 10501-10514.
Read now

Articles from other publishers (17)

Ji-Hea Kim, Ka-Won Kang, Yong Park & Byung Soo Kim. (2023) CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26). Heliyon 9:11, pages e22091.
Crossref
C. Jiang, F. Xu, D. Yi, B. Jiang, R. Wang, L. Wu, H. Ding, J. Qin, Y. Lee, J. Sang, X. Shi & L. Su. (2023) Testosterone promotes the migration, invasion and EMT process of papillary thyroid carcinoma by up-regulating Tnnt1. Journal of Endocrinological Investigation.
Crossref
Ningning Sun, Beyongsam Chu, Dong-Hyun Choi, Leejin Lim & Heesang Song. (2023) ETV2 Enhances CXCL5 Secretion from Endothelial Cells, Leading to the Promotion of Vascular Smooth Muscle Cell Migration. International Journal of Molecular Sciences 24:12, pages 9904.
Crossref
Zheng-zheng Wang, Xiao-ting Li, Qing-jun Li & Jin-xue Zhou. (2022) Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression. Digestive Diseases and Sciences 68:3, pages 841-851.
Crossref
Kyle H. Bond, Sunder Sims-Lucas & Leif Oxburgh. (2022) Targets for Renal Carcinoma Growth Control Identified by Screening FOXD1 Cell Proliferation Pathways. Cancers 14:16, pages 3958.
Crossref
Jie Deng, Rongqi Jiang, Enqing Meng & Hao Wu. (2022) CXCL5: A coachman to drive cancer progression. Frontiers in Oncology 12.
Crossref
Stephen Halada, Victoria Casado-Medrano, Julia A Baran, Joshua Lee, Poojita Chinmay, Andrew J Bauer & Aime T Franco. (2022) Hormonal Crosstalk Between Thyroid and Breast Cancer. Endocrinology 163:7.
Crossref
Hongyi Li, Min Wu & Xia Zhao. (2022) Role of chemokine systems in cancer and inflammatory diseases. MedComm 3:2.
Crossref
Junjie Wang, Qin Fan, Tengbo Yu & Yingze Zhang. (2021) Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis. BMC Genomic Data 22:1.
Crossref
Yan Zhang, Sheng Zheng, Nansheng Liao, Huifeng Huang, Wenxiao Chen, Zhenxing Wu & Deqing Wu. (2021) CircCTNNA1 acts as a ceRNA for miR-363-3p to facilitate the progression of colorectal cancer by promoting CXCL5 expression. Journal of Biological Research-Thessaloniki 28:1.
Crossref
El-Shaimaa A. Arafa, Mohamed S. Refaey, Omnia A.M. Abd El-Ghafar, Emad H.M. Hassanein & Ahmed M. Sayed. (2021) The promising therapeutic potentials of ginsenosides mediated through p38 MAPK signaling inhibition. Heliyon 7:11, pages e08354.
Crossref
Haiyan Li, Feng Liu, Xiaoyang Wang, Menglong Li, Zhihui Li, Yongmei Xie & Yanzhi Guo. (2021) Identification of Hub lncRNAs Along With lncRNA-miRNA-mRNA Network for Effective Diagnosis and Prognosis of Papillary Thyroid Cancer. Frontiers in Pharmacology 12.
Crossref
Min Yu, Xiaokun Ma, Dudu Jiang, Lijing Wang, Qing Zhan & Jiangmin Zhao. (2021) CXC chemokine ligand 5 (CXCL5) disrupted the permeability of human brain microvascular endothelial cells via regulating p38 signal. Microbiology and Immunology 65:1, pages 40-47.
Crossref
Bernardo L. Rapoport, Helen C. Steel, Annette J. Theron, Teresa Smit & Ronald Anderson. (2020) Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy. Molecules 25:7, pages 1618.
Crossref
Quhui Wang, Muqi Shi, Shiqi Sun, Quan Zhou, Li Ding, Chenxia Jiang, Tingting Bian, Feng Jia, Yifei Liu & Jun Qin. (2020) CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway. Biochemical and Biophysical Research Communications 524:3, pages 656-662.
Crossref
Wen-Juan Tian, Shan-Shan Liu & Bu-Rong Li. (2020) The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer. Technology in Cancer Research & Treatment 19, pages 153303382097750.
Crossref
Yuanbo Xue, Jing Li & Xiubo Lu. (2020) A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma. Technology in Cancer Research & Treatment 19, pages 153303382093586.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.